We demonstrate that increased NKG2D expressions in all three CD56bright, CD56dim, and CD56− NK subsets were weakly but significantly associated with higher UPDRS scores in PD patients (Table 2), suggesting that a potential link between NKG2D expression and the severity of Parkinson’s symptoms, as measured by the UPDRS scores. The gene discussed is KLRK1; the disease is Parkinson disease.